John Strouse: Grateful for ASH’s Support and for the Privilege of Working with Charity Oyedeji
John Strouse, Associate Professor of Medicine at Duke University Medical Center, shared on LinkedIn:
“I am glad that ASH exists to support researchers through this time of unprecedented disruption to research and the healthcare in the United States and that I have the privilege of working with Charity Oyedeji!”
Quoting American Society of Hematology’s post:
“This past summer, the National Institutes of Health cut funding for a sickle cell disease initiative led by Charity Oyedeji, before it was complete. The Sickle Cell Disease (SCD) Functional Assessment Validation and Refinement (SILVR) Study and the SickleFit Exercise Program were focusing on physical capabilities and independence for patients with SCD. Beyond disrupting patient care, such funding cuts may also discourage researchers, particularly those from underrepresented backgrounds, from pursuing vital work in hematology and SCD research.
Learn more and help protect critical research in hematology here.”
Get the latest ASH updates on Hemostasis Today.
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage